Bart Westendorp
Impact in
- Cancer Research top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
- Oncology 16
- Cancer-related Molecular Pathways 11
-
- Renin-Angiotensin System Studies 6
- Heart Failure Treatment and Management 4
- Co-authors
- Alain de BruinShusil K. PanditPeter C.J. TootenMichal MokrýM.J.M. ToussaintFrank C. P. HolstegeMarian J.A. Groot KoerkampEdwin Cuppen
- Journals
- Oncogene (4 papers)The EMBO Journal (3 papers)European Journal of Pharmacology (2 papers)Molecular Cancer Research (2 papers)EMBO Reports (2 papers)
- Partner nations
- NetherlandsUnited StatesPakistan
In The Last Decade
Bart Westendorp
37 papers receiving 865 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 167
- Oncology 270
- Cell Biology 152
- Molecular Biology 604
- Hepatology 62
Countries citing papers authored by Bart Westendorp
This map shows the geographic impact of Bart Westendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Westendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Westendorp more than expected).
Fields of papers citing papers by Bart Westendorp
This network shows the impact of papers produced by Bart Westendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Westendorp. The network helps show where Bart Westendorp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart Westendorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 19 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 28 | |
| 8 | 2017 | 5 | |
| 9 | 2017 | 18 | |
| 10 | 2016 | 52 | |
| 11 | 2013 | 17 | |
| 12 | 2012 | 124 | |
| 13 | 2011 | 96 | |
| 14 | 2005 | 6 | |
| 15 | 2005 | 8 | |
| 16 | 2005 | 9 | |
| 17 | 2005 | 6 | |
| 18 | Withdrawing chronic quinapril treatment causes rebound volume overload and endothelial dysfunction in rats with myocardial infarction | 2004 | 0 |
| 19 | Hydrochlorothiazide increases tissue concentrations of the ACE inhibitor zofenoprilat in rats with myocardial infarction | 2004 | 0 |
| 20 | 2004 | 0 |
About Bart Westendorp
Bart Westendorp is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology, Cancer Research and Cell Biology, having authored 41 papers that have together received 869 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), DNA Repair Mechanisms (7 papers), Ubiquitin and proteasome pathways (7 papers), Renin-Angiotensin System Studies (6 papers), Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (5 papers), Microtubule and mitosis dynamics (4 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Cancer Research (167 citations), Oncology (270 citations), Cell Biology (152 citations), Molecular Biology (604 citations) and Hepatology (62 citations). Bart Westendorp has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include Alain de Bruin, Shusil K. Pandit, Peter C.J. Tooten, Michal Mokrý, M.J.M. Toussaint, Frank C. P. Holstege, Marian J.A. Groot Koerkamp, Edwin Cuppen, Walbert J. Bakker and Sathidpak Nantasanti. Their work appears in journals such as Oncogene, The EMBO Journal, European Journal of Pharmacology, Molecular Cancer Research and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.